ICER Seeks to Halt Treatment Innovation for MS Patients

ICER Seeks to Halt Treatment Innovation for MS Patients

More than 400,000 Americans are living with multiple sclerosis, and for every single MS patient, it can take years to find the right treatment. The patient’s journey got a little bit easier this spring, when the U.S. Food and Drug Administration approved a new...
Multiple Sclerosis 2019

Multiple Sclerosis 2019

Patients Rising Now advocates on behalf of patients with life-threatening conditions and chronic diseases for them to have access to vital therapies and services. Access is a matter of survival and quality of life for those patients, and it spans affordability,...